Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)

Clinical trial NCT02628067 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02628067
Sponsor: Merck Sharp & Dohme LLC
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Cancer Anal Carcinoma Anal Cancer Biliary Cancer Cholangiocarcinoma Bile Duct Cancer Neuroendocrine Tumor Carcinoid Tumor Endometrial Carcinoma Endometrial Cancer Cervical Carcinoma Cervical Cancer

Start date: 2015-12-18
Primary completion: 2027-05-04
Enrollment: 1609

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.